Format

Send to

Choose Destination
Transplant Proc. 2018 Mar;50(2):536-538. doi: 10.1016/j.transproceed.2017.11.051.

Results of Controlled Donation After Circulatory Death in a Third-Level Hospital.

Author information

1
Intensive Care Unit, University Hospital Virgen del Rocío, Sevilla, Spain. Electronic address: norapalomolpz@gmail.com.
2
Transplant Coordinator Huelva-Sevilla, University Hospital Virgen del Rocío, Sevilla, Spain.
3
Intensive Care Unit, University Hospital Virgen del Rocío, Sevilla, Spain.

Abstract

OBJECTIVE:

To investigate the characteristics and evolution of controlled donation after circulatory death (DCD) type III.

MATERIALS AND METHODS:

Observational and retrospective study of controlled DCD type III of donors conducted from 2014 to 2016. Clinical data, intensive care unit (ICU) stay, cause of death, warm ischemia time, and total time were collected. Delayed graft function (DGF) and survival of renal transplant were also registered. Qualitative variables are described as frequencies and absolute values and quantitative variables as medians and interquartile ranges.

RESULTS:

A total of 21 donors were collected; 71% (15) were males, median age was 55 years (interquartile range [IR] 48-72), and median ICU stay was 7 days (IR 4-12). The main cause of death was anoxic encephalopathy (57%, 12), followed by intracerebral hemorrhage (28%, 6). In 48%, withdrawal of life support occurred in the operating room, and 98% of donors were preserved by abdominal super-rapid cannulation technique. Average warm ischemia time was 20 minutes (IR 16-24), and total ischemia time was 26 minutes (IR 23-34). Of the donations, 57% were livers and 90% were kidneys. Out of 42 kidneys donated, 54% (23) of them were valid. Median renal transplant hospital stay was 18 days (IR 6-24), and 46% develop DGF. Survival at discharge was 100%.

CONCLUSION:

DCD type III ensures a source of organs. The main cause of death was anoxic encephalopathy. Most donors were able to donate some solid organ.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center